Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Evaluate the efficacy, Safety and Pharmacokinetics of Intravenous single injection LC28-0126 immediately before PCI (Percutaneous Coronary Intervention) in Patients with STEMI (ST-segment Elevation Myocardial Infarction)

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: LG Life Sciences

Criteria

Inclusion Criteria:

• Age between 20 and 75

• Within 12 hours after the onset of chest pain

• ST-segment elevation of more than 0.1 mV in two contiguous leads or new LBBB(left bundle-branch block) patients

• Signed for written informed consent

Exclusion Criteria:

• Left Main disease

• Multi-vessel disease